UK markets close in 4 hours 4 minutes

Eliem Therapeutics, Inc. (ELYM)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
8.29+0.54 (+6.97%)
At close: 04:00PM EDT
8.14 -0.15 (-1.81%)
After hours: 07:12PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close7.75
Open7.74
Bid8.13 x 100
Ask8.40 x 100
Day's range7.59 - 8.36
52-week range2.35 - 11.55
Volume106,612
Avg. volume916,540
Market cap246.647M
Beta (5Y monthly)-0.31
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
All
News
  • GlobeNewswire

    Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

    Transaction to add clinical-stage program directed towards treating unmet needs in autoantibody-mediated diseases Combined company expected to have approximately $210 million of cash and cash equivalents, including $120 million from a concurrent private placement of common stock from leading life sciences investors Combined company to focus on clinical development of lead product candidate, TNT119, in upcoming Phase 2 clinical trials in systemic lupus erythematosus and immune thrombocytopenia Co